Categories
Latest Industry Intelligence
This latest ebook sponsored by Sino Biological features insight on how the global drug discovery and [...]
Cell therapy research has never been more exciting with all of the research ongoing. Download [...]
…the second half of 2023, with additional long-term follow-up data on safety, T-cell immunity, and durability of immune responses. Dr Melanie Saville, Executive Director of R&D at CEPI, said: “Covid-19…
…decision-making There will be one more episode this week, called: Harnessing the power of data science and AI in life sciences If you are attending the event, you stand a…
…and progress these through the Design-Make-Test-Analyse (DMTA) cycle. A smooth interface between data and humans drives down DMTA cycle times and shortens the path to clinical candidates. Mari Goldsmith, Application…
…disease (IPD). The company plans to initiate the infant Phase II study in the second quarter of 2023, with topline safety, tolerability and immunogenicity data following the primary three-dose immunisation…
…data and how we can connect lab automation to decisions. Previous episodes in this series include: A Welcome to SLAS 2023 Acquiring deeper insights and acceleration with AI Over the…
…UQ’s Institute for Molecular Bioscience said there was no vaccine for prevention of Strep A, but efficacy data from the team’s preclinical studies was promising. “The support from the Leducq…
…Institute of Personalized Medicine, and System Chief, Division of Data Driven and Digital Medicine (D3M), Department of Medicine. Huge dataset Researchers used the National COVID Cohort Collaborative (N3C) database, the…
…three more episodes, which include: Connecting lab automation to decision-making How machine learning and lab automation are changing the future of protein therapeutics Harnessing the power of data science and…
Menu ≡ ╳ 
